vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and Origin Bancorp, Inc. (OBK). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $104.0M, roughly 1.4× Origin Bancorp, Inc.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs 6.2%, a 20.4% gap on every dollar of revenue. Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 3.9%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

GKOS vs OBK — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.4× larger
GKOS
$150.6M
$104.0M
OBK
Higher net margin
OBK
OBK
20.4% more per $
OBK
26.6%
6.2%
GKOS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
3.9%
OBK

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GKOS
GKOS
OBK
OBK
Revenue
$150.6M
$104.0M
Net Profit
$9.4M
$27.7M
Gross Margin
77.9%
Operating Margin
9.0%
Net Margin
6.2%
26.6%
Revenue YoY
41.2%
Net Profit YoY
EPS (diluted)
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
OBK
OBK
Q1 26
$150.6M
$104.0M
Q4 25
$143.1M
$103.4M
Q3 25
$133.5M
$109.8M
Q2 25
$124.1M
$83.5M
Q1 25
$106.7M
$94.1M
Q4 24
$105.5M
$78.3M
Q3 24
$96.7M
$90.8M
Q2 24
$95.7M
$96.4M
Net Profit
GKOS
GKOS
OBK
OBK
Q1 26
$9.4M
$27.7M
Q4 25
$-133.7M
$29.5M
Q3 25
$-16.2M
$8.6M
Q2 25
$-19.7M
$14.6M
Q1 25
$-18.1M
$22.4M
Q4 24
$-33.6M
$14.3M
Q3 24
$-21.4M
$18.6M
Q2 24
$-50.5M
$21.0M
Gross Margin
GKOS
GKOS
OBK
OBK
Q1 26
77.9%
Q4 25
-1.1%
Q3 25
78.4%
Q2 25
78.3%
Q1 25
77.2%
Q4 24
72.9%
Q3 24
76.6%
Q2 24
76.4%
Operating Margin
GKOS
GKOS
OBK
OBK
Q1 26
9.0%
Q4 25
-97.7%
36.2%
Q3 25
-12.3%
10.0%
Q2 25
-18.3%
22.3%
Q1 25
-19.4%
30.4%
Q4 24
-27.2%
23.0%
Q3 24
-25.5%
26.1%
Q2 24
-31.3%
27.7%
Net Margin
GKOS
GKOS
OBK
OBK
Q1 26
6.2%
26.6%
Q4 25
-93.4%
28.5%
Q3 25
-12.2%
7.9%
Q2 25
-15.8%
17.5%
Q1 25
-17.0%
23.8%
Q4 24
-31.8%
18.2%
Q3 24
-22.1%
20.5%
Q2 24
-52.8%
21.8%
EPS (diluted)
GKOS
GKOS
OBK
OBK
Q1 26
$0.89
Q4 25
$-2.34
$0.95
Q3 25
$-0.28
$0.27
Q2 25
$-0.34
$0.47
Q1 25
$-0.32
$0.71
Q4 24
$-0.56
$0.45
Q3 24
$-0.39
$0.60
Q2 24
$-1.00
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
OBK
OBK
Cash + ST InvestmentsLiquidity on hand
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
$1.3B
Total Assets
$893.3M
$10.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
OBK
OBK
Q1 26
$276.7M
Q4 25
$90.8M
$424.2M
Q3 25
$98.2M
$626.9M
Q2 25
$100.8M
$334.1M
Q1 25
$114.3M
$486.2M
Q4 24
$169.6M
$470.2M
Q3 24
$100.1M
$321.2M
Q2 24
$68.1M
$288.1M
Stockholders' Equity
GKOS
GKOS
OBK
OBK
Q1 26
$670.9M
$1.3B
Q4 25
$656.2M
$1.2B
Q3 25
$769.5M
$1.2B
Q2 25
$765.1M
$1.2B
Q1 25
$764.0M
$1.2B
Q4 24
$766.9M
$1.1B
Q3 24
$668.5M
$1.1B
Q2 24
$665.2M
$1.1B
Total Assets
GKOS
GKOS
OBK
OBK
Q1 26
$893.3M
$10.2B
Q4 25
$893.5M
$9.7B
Q3 25
$999.4M
$9.8B
Q2 25
$987.0M
$9.7B
Q1 25
$966.2M
$9.8B
Q4 24
$974.8M
$9.7B
Q3 24
$926.5M
$10.0B
Q2 24
$919.7M
$9.9B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GKOS
GKOS

Segment breakdown not available.

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

Related Comparisons